Clinical Research Directory
Browse clinical research sites, groups, and studies.
Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)
Sponsor: CooperVision International Limited (CVIL)
Summary
The main objective of this post market clinical study is to evaluate the effectiveness and safety of the Paragon CRT®100 Contact Lens.
Official title: Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D) Rigid Gas Permeable Contact Lenses for Corneal Refractive Therapy for Temporary Myopic Refractive Power Reduction
Key Details
Gender
All
Age Range
8 Years - Any
Study Type
INTERVENTIONAL
Enrollment
250
Start Date
2019-08-29
Completion Date
2020-12-31
Last Updated
2019-12-05
Healthy Volunteers
Yes
Conditions
Interventions
Paragon CRT®100 Contact Lens
Paragon CRT® 100 Contact Lenses for Corneal Refractive Therapy are indicated for use in the reduction of myopic refractive error in nondiseased eyes.
Locations (4)
Changsha Aier Eye Hospital
Shanghai, China
Eye & ENT Hospital of Fudan University
Shanghai, China
Tianjin Eye Hospital
Tianjin, China
The Affiliated Eye Hospital of Wenzhou Medical University
Wenzhou, China